Evidence map›Paper›PMID 26063499›Full record

ArticleJournal of ovarian research2015

Lipoic acid decreases Mcl-1, Bcl-xL and up regulates Bim on ovarian carcinoma cells leading to cell death.

Perrine Kafara, Philippe Icard, Marilyne Guillamin, Laurent Schwartz, Hubert Lincet

Open access · goldAbstract read
In one paragraph

Article in Journal of ovarian research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Metabolic Strategies for Inhibiting Cancer Development.Advances in nutrition (Bethesda, Md.) · 2021
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Perrine KafaraINSERM, U 1199, Unité BioTICLA, Caen, F-14032, France. perrinekafara@hotmail.fr.
Philippe IcardINSERM, U 1199, Unité BioTICLA, Caen, F-14032, France. philippe.icard@hotmail.fr.
Marilyne GuillaminINSERM, U 1199, Unité BioTICLA, Caen, F-14032, France. m.guillamin@baclesse.fr.
Laurent SchwartzUMR 7161, Laboratoire d'Informatique LIX, Ecole Polytechnique, 91128, Palaiseau Cedex, France. schwartz@lix.polytechnique.fr.
Hubert LincetUMR INSERM U1052, CNRS 5286, Centre de Recherche en Cancérologie de Lyon, Lyon, France. hubert.lincet@univ-lyon1.fr.
Centre François Baclesse · FRCentre National de la Recherche Scientifique · FRÉcole Polytechnique · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOvarian carcinoma is the leading cause of death from gynecological cancer because there is risk of chemoresistance. As previously demonstrated in our laboratory, Alpha-lipoic acid (LA), a co-factor for metabolic enzymes, suppresses the tumor growth. In this study, we have researched the mechanisms that are responsible for the activity of LA.

methodsWe have studied the mechanisms of LA in two ovarian cancer cell lines, a cisplatin sensitive one, IGROV1 and its resistant counterpart, IGROV1-R10. These cells have been exposed to lipoic acid at various concentrations. Cell proliferation, cell cycle repartition and nuclear staining with DAPI were recorded. Western blot analyses were performed to detect various proteins implied in apoptotic cell death pathways. To investigate the formation of ROS, the oxidation of CM-DCFH2-DA were also determined.

findingsLA suppressed growth proliferation and induced apoptosis in both ovarian cell lines. Moreover, LA provoked a down regulation of two anti-apoptotic proteins, Mcl-1 and Bcl-xL protein and a strong induction of the BH3-only protein Bim. Furthermore, LA induced ROS generation which could be involved in the CHOP induction which is known to activate the Bim translation.

conclusionsOur results reveal novel actions of LA which could explain the anti-tumoral effects of the LA. Therefore, LA seems to be a promising compound for ovarian cancer treatment.

Indexed as

ApoptosisApoptosis Regulatory ProteinsBcl-2-Like Protein 11bcl-X ProteinCarcinomaCell Line, TumorCisplatinDrug Resistance, NeoplasmFemaleGene Expression Regulation, NeoplasticHumansMembrane ProteinsMyeloid Cell Leukemia Sequence 1 ProteinOvarian NeoplasmsProto-Oncogene ProteinsRNA InterferenceApoptosis Regulatory ProteinsBCL2L11 protein, humanBCL2L1 protein, humanBcl-2-Like Protein 11bcl-X ProteinCisplatinMCL1 protein, humanMembrane ProteinsMyeloid Cell Leukemia Sequence 1 ProteinProto-Oncogene ProteinsThioctic Acid

Identifiers

PMID26063499
PMCPMC4470044
OpenAlexW2171154954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.